Johnson & Johnson preparing to seek approval of its Covid-19 vaccine

Washington, Jan 29 (EFE).- Johnson & Johnson said Friday that its prospective Covid-19 vaccine has proven 66 percent effective in protecting against moderate to severe coronavirus and 85 percent...

Metadata

Date: 29/01/2021 19:43 (UTC)
Credit: EFE
Source: EFE
Topic: Health » Epidemic and plague
Reference: 181000164710
Relevance: Normal

Content included in the following products:

Efedata

Product Suggestions

Stories

Reportajes general América

Text

EFE International News

Photo

EFE Photo

Multimedia

Contenidos digitales general multimedia América

Photo

Gráfico general y gráfico territorial EUA-Caribe.

Photo

Gráfico general América

Video

EFE VÍDEO

Text

EFE News Latino